Data on ER status were available for 75.8% of EA cases and 72.5% of AA cases, and AA cases were more likely than EA cases to be diagnosed with ER negative breast cancer (20.1% versus 15.5%, P=0.007). The gene discussed is ESR1; the disease is breast cancer.